Business
THE RESILIENCE DOCTRINE: 5 Assets Securing the 2026 Sovereign Stack
VANCOUVER, British Columbia, Jan. 26, 2026 (GLOBE NEWSWIRE) --   Equity Insider Market I...
About this update from Rua Gold Inc
[{"type":"text","content":"THE RESILIENCE DOCTRINE: 5 Assets Securing the 2026 Sovereign StackIssued on behalf of Ventripoint Diagnostics Ltd.\nVANCOUVER, British Columbia, Jan. 26, 2026 (GLOBE NEWSWIRE) --  Equity Insider Market Intelligence Brief – The global market has entered a cycle of defensive hardening. After a decade of aggressive speculation, the defining theme of 2026 is Resilience. Investors are realizing that the systems powering the modern world—from the energy grid to the human body—are dangerously fragile. The \"Everything Bubble\" ignored physical and biological reality. Now reality is repricing the market. Capital is rotating into the \"Sovereign Stack\": the critical minerals that cannot be substituted, the supply chains that must be domesticated, and the biological technologies that extend the lifespan of the workforce. The companies profiled below are not selling convenience. They are selling survival. They own the tungsten for the missiles, the fluorspar for the steel, the gold for the vault, and the cellular tech to repair the human machine. This is the Resilience Doctrine. THE BIOLOGICAL INFRASTRUCTURE Avant Technologies Inc. (OTCQB: AVAI) has executed a decisive pivot into regenerative medicine, targeting the most critical vulnerability in the modern economy: the biological collapse of the human workforce. While the market obsesses over upgrading the digital grid, Avant is upgrading the human operator. Chronic disease and accelerated aging are the rust of the labor force. Avant is building the anti-corrosion layer. The transformation began on November 4, with the formation of Insulinova, a joint venture designed to functionally restore insulin production in diabetics. This is not management. This is restoration. Two weeks later, on November 18, the company secured an exclusive license for Klotho-producing cells. Klotho is the longevity protein, the biological marker that declines with age and correlates directly with organ deterioration and mortality risk. The thesis is blunt: A nation cannot compete if its population is sick. Avant is positioning itself as the primary engineer of biological resilience, delivering the cellular upgrades required to sustain a high-performance economy. Read this and more news for Avant at: https://equity-insider.com/2025/03/21/unlocking-the-trillion-dollar-ai-market-what-inv...